Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs™ trauma screw
Bioretec Ltd Inside information 4 November 2022 at 6:15 p.m. EETBioretec Ltd, a pioneer in biodegradable orthopedic implants, expects the European marketing authorization for the RemeOs™ trauma screw to be delayed from the original estimate of 2022. The company estimates, based on the stage of its own registration process and the latest reports on certifications in the healthcare industry, that obtaining a market authorization will move to 2023. The review process of the CE mark application is ongoing, and the company is still waiting for the feedback from the Notified Body on main